SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-022074
Filing Date
2024-04-25
Accepted
2024-04-25 16:26:39
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-25

Document Format Files

Seq Description Document Type Size
1 ARS ef20027730_ars.pdf ARS 1285923
  Complete submission text file 0001140361-24-022074.txt   1772530
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-23186 | Film No.: 24876779
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)